Recently released retail sales data for year ending 2007 (IRI) indicate a 19% increase in dollar sales volume and a 9% increase in unit sales of Coenzyme Q10. - January 23, 2008 - ZMC-USA

AnaSpec has announced the availability of a wide selection of T-Cell Epitopes, available both individually and pooled. - January 23, 2008 - AnaSpec, Inc.

At Mitamins, a new supplement formula targeted at Lupus from Dr. Balch has been launched. This natural lupus treatment formula is designed to control the symptoms of lupus as well as promote overall health. Botanicals, such as ginger, having strong anti-inflammatory properties are included. The supplement... - January 23, 2008 - Mitamins Inc.

Mitamins launches a formula by Dr. Balch that is specified to target Hypothyroidism. It contains Vitamins A, C, D, E, K, B-6, and B-12, as well as the nutrients Calcium, Iodine, Magnesium, Thiamin, Riboflavin, Niacin, Folate, Biotin, Copper, Selenium, Maganese, Chromium, Potassium, Pantothenic Acid,... - January 21, 2008 - Mitamins Inc.

Dr. Balch has launched a Mitamins supplement designed to target Tinnitus. This supplement contains Vitamins B-12 and B-6, as well as the nutrients Thiamin, Riboflavin, Niacin, Folate, Biotin, Magnesium, Zinc, Copper, and Pantothenic Acid. It also includes Choline Bitartrate, Inositol, PABA, and Gingko Extract. - January 21, 2008 - Mitamins Inc.

Mitamins launches a new formula from Dr. Balch that is specified to target Narcolepsy. This supplement contains a complete spectrum of B vitamins, which are especially nourishing to the brain: Thiamin, Riboflavin, Niacin, Vitamin B12, Folate, Pantothenic Acid and Vitamin B6. The formula also includes an Amino Acid Mix, as well as L-Tyrosine, L-Glutamine, Lecithin and Ginkgo Extract. Necessary minerals such as Calcium, Magnesium and Chromium are included as well. - January 21, 2008 - Mitamins Inc.

From Sunnyvale, California - At Mitamins, a new supplement formula from Dr. Balch, which is targeted at Emphysema has been launched. This natural emphysema formula is focused on lung system recovery and repair. Botanicals such as Ginkgo Biloba, used to help with peripheral circulation, are included alongside powerful immunity-enhancing components such as Astragalus. Smoking- and stress-related nutritional deficiencies are addressed with a variety of essentials. - January 21, 2008 - Mitamins Inc.

Industry expert Scott Rosenbush strongly recommends vitamin K2 supplementation to help ensure bone and heart health. As the most bioactive and longest lasting form of vitamin K, menaquinone-7 is ideal for dietary supplements and functional foods. - January 19, 2008 - P.L. Thomas & Co., Inc.

ANAVEX 7-1037 has been shown to kill human HCT116 colon cancer cells in advanced pre-clinical studies. - January 16, 2008 - Anavex Life Sciences Corp.

Results from animal model testing demonstrate ANAVEX 1-41 has significant neuroprotective and anti-amnesic benefits. - January 16, 2008 - Anavex Life Sciences Corp.

Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL - News) announces the appointment of Dr. Cameron Durrant to its Board of Directors. - January 16, 2008 - Anavex Life Sciences Corp.

Denver-based Company introduces foolproof, privacy-friendly biometric security technology. - January 11, 2008 - Platinum Broadcasting Company - Featured Press Release

Media Solutions Company presents Innovative new proxemic marketing products. - January 11, 2008 - Platinum Broadcasting Company - Featured Press Release

Pioneering Innovations in Network Security. - January 11, 2008 - Platinum Broadcasting Company - Featured Press Release

Trevigen announces the immediate availability of PathClear" Basement Membrane Extract in the Cultrex® product line. - January 11, 2008 - Trevigen, Inc

Axium Healthcare Pharmacy announced today that it has been awarded the clinical trial management contract for OxThera’s Oxabact™. Oxabact™ is manufactured by OxThera. - January 09, 2008 - Axium Healthcare Pharmacy, Inc.

Samaritan has appointed two new independent members, Jack L. Ayala and Robert W. Crane, to its Board of Directors. Mr. Ayala and Mr. Crane bring valuable experience and their appointment strengthens Samaritan's commitment to maintain a majority of independent members that reflects today's best practices on its Board. Samaritan's board is now comprised of eight independent directors and two internal directors. - January 09, 2008 - Samaritan Pharmaceuticals

Samaritan has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 09, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals has received a notice that a European Patent has been granted to Samaritan's SP-1000 (Cholesterol Recognition Sequence) drug for the treatment of cardiovascular disease. - January 09, 2008 - Samaritan Pharmaceuticals

Enters Service Agreement with Advinus Therapeutics, India to Validate Potential Memory Restoring Benefits of Alzheimer's Drug Caprospinol. Strategy is to Bolster Caprospinol Alzheimer's Data Package to Out-License to Big Pharma and Expand IND Application to Enter Human Trials. Samaritan Pharmaceuticals... - January 09, 2008 - Samaritan Pharmaceuticals

The CentraState HealthWatch cable TV show featuring Freehold, NJ orthopedic surgeon Dr Alan Nasar, has been extended through January across an increased number of New Jersey television stations. Alan S. Nasar MD, a fellowship-trained joint replacement orthopedic surgeon at the Advanced Orthopedics and Sports Medicine Institute in Freehold, features in one segment of the half-hour show discussing advances in joint replacement surgery and pain management with host Gary Gellman. - January 07, 2008 - Advanced Orthopedics and Sports Medicine Institute, PC

Effective January 1, 2008, DDC's Laboratory Director, Dr. Michael Baird, is chairman of the Chair of the Relationship Testing Standards Program Unit of the AABB (formerly American Association of Blood Banks). In this capacity, Dr. Baird is leading the committee to develop the 9th edition of the Standards... - January 05, 2008 - DNA Diagnostics Center

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced ten (10) new catalog peptides and one new unusual amino acid. MSL8; [Met256]-OVA (257-264)- Cat# 62573-5 Sequence: MSIINFEKL MSL8; [Met256]-OVA (257-264)- Cat# 62573-1 Sequence: MSIINFEKL OVA (257-264);... - January 04, 2008 - AnaSpec, Inc.

The U.S. Food and Drug Administration (FDA) has completed its regulatory review of Samaritan's IND (Investigational New Drug) application for Cushing's syndrome SP-6300 and declared it has not identified any deficiencies in its IND filing. Accordingly, Samaritan can proceed with its proposed Phase II clinical study of Cushing's syndrome SP-6300's efficacy in patients experiencing Hypercortisolism. - January 04, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals, Inc. is pleased to announce that its subsidiary Samaritan Pharmaceuticals Europe, S.A. has received notification, from the Cyprus Ministry of Health, that its marketing authorization for HIV fungus drug Amphocil has been approved in Cyprus. The Cyprus Ministry of Health is... - January 03, 2008 - Samaritan Pharmaceuticals

Ms. Anna Strasberg has joined Samaritan's Advisory Board. Anna Strasberg is best known for continuing the Actors Studio, where the work of her husband Lee Strasberg nurtured the talents of celebrities like Marlon Brando, Robert De Niro, Harvey Keitel, Paul Newman and Al Pacino. - January 03, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals has signed an exclusive licensing and distribution agreement with Three Rivers Pharmaceuticals, LLC for fungal infection drug Amphocil to add the territory of Ireland. Currently, Samaritan has the marketing rights for Amphocil in Greece and Cyprus and has successfully registered and obtained a price increase for Amphocil in Greece. - January 03, 2008 - Samaritan Pharmaceuticals

Samaritan Pharmaceuticals, Inc. has signed an exclusive distribution agreement with EUSA Pharma to launch, promote, sell and support pain patch Rapydan in Greece and Cyprus. - January 03, 2008 - Samaritan Pharmaceuticals

Unparalleled drug-free gains in strength, stamina and mental performance attainable through natural energetic alternative to steroids and banned performance enhancing drugs providing powerful ergogenic effects rivaling steroids, blood doping and other dangerous performance enhancement techniques while enhancing deep delta sleep, cardiovascular efficiency, cellular repair and mental acuity. - January 01, 2008 - EarthPulse Technologies, LLC

The annual art camp by the RPG Academy of Art concluded with a warm brunch at the Marve beach house today. Pristine white was the theme of the locale and the breezy touch of sea winds along with the live band playing some groovy numbers got the enchantment heightened. After the week-long camp, the participating... - December 30, 2007 - RPG

Whole Youth brings the Annique Rooibos red tea, green tea and blended herbal teas to the USA. The complete Annique range is manufactured in South Africa from the Rooibos (red bush) plant and includes cosmetics skin care as well as the newly introduced line of Rooibos teas. - December 29, 2007 - Whole Youth

The “Clinical and Economical Considerations For IV Push Drug Delivery” technical paper – authored by Industry Expert Richard Rosenfeld, RPh, MBA, for Baxa Corporation – is now accessible at Expert411.com for media and professional reference. The paper is an overview of the historical background for IV push and a model for implementation of a successful program. - December 27, 2007 - Baxa Corporation - Featured Press Release

A new product for Stop Smoking with AcuAids providing a comprehensive approach. - December 21, 2007 - AcuAids - Featured Press Release

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced sixteen (16) new catalog peptides. [Cys17]-beta-Amyloid (1-17)- Cat# 62473 This peptide amino acids 1 to 17 is a modified fragment of the b-amyloid peptide; with cysteine substituted for valine at... - December 20, 2007 - AnaSpec, Inc.

AnaSpec has introduced its first quantitative and homogeneous colorimetric MMP assay kit. - December 19, 2007 - AnaSpec, Inc.

Scientists recently released the results of the first ever national survey which assessed nurses’ extent and frequency of exposures to common health care hazards. - December 19, 2007 - carmel pharma, inc. - Featured Press Release

A “Gnu” movement is taking hold across the country. People everywhere are chanting, “I want my fiber”. Dietary fiber, that is. People nationwide are proclaiming that the delicious Flavor & Fiber Bars, made by Gnu Foods, are the inspiration for their fiber-obsession. They are... - December 18, 2007 - Gnu Foods, LLC

AnaSpec introduces a new line of labeled amyloid peptides. - December 16, 2007 - AnaSpec, Inc.

Freehold Orthopedic surgeon Alan S. Nasar, MD delivered the final lecture for the year “Hip Arthroscopy, Hip Resurfacing and Hip Replacement; Are You a Candidate?” to a welcoming audience, mainly members of the local community, on Tuesday, December 11th, at the CentraState Healthcare Center in Freehold, New Jersey. Dr Nasar, Director of the Total Joint Center of New Jersey, is one of the team of orthopedic surgeons from the Advanced Orthopedics and Sports Medicine Institute in Freehold, NJ. - December 16, 2007 - Advanced Orthopedics and Sports Medicine Institute, PC

Continuing to rapidly expand its antibody offerings, AnaSpec added ten (10) new catalog antibodies to its growing collection. Anti-ATF2 (pT69/71) - Cat# 54323, 50 µg/250 µl Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Zebrafish; Bovine; Applications: WB Anti-ATF2 (paired69/71)... - December 15, 2007 - AnaSpec, Inc.

Pulsed magnetic fields provide strong anti-aging effects while enhancing physical performance in older pets where trauma, arthritis or age related joint deformity has resulted in chronic pain, loss of mobility and subsequent changes in behavior. - December 14, 2007 - EarthPulse Technologies, LLC

With a collection that has been rapidly expanded in the last few years, AnaSpec has organized its growing selection of antibodies into its newest antibodies brochure. The brochure showcases: • Primary antibodies • HRP, AP and biotin conjugated secondary antibodies • Patented HiLyte™... - December 14, 2007 - AnaSpec, Inc.

Over half of heavy drinking parents underestimate, or lie about, their consumption of alcohol, according to the first large-scale scientific survey using hair samples. The hair samples were collected from 200 parents of young children from across the UK, with an equal split between mothers and fathers... - December 14, 2007 - Trimega Laboratories Ltd

South Seas Pharmaceuticals.S.A. today announced that Dr. Agueda Pedreshchi had joined the Medical Tourism team for “Treatment Abroad” offered by South Seas Pharmaceuticals in Panama. - December 13, 2007 - South Seas Pharmaceuticals S.A.

Cardiovascular Sciences, Inc. (CVSC), a corporation under the laws of Nevada, is excited to reveal an initial funding event with Seven Palm Investments, LLC of Illinois. After a recent assessment and restructuring of the company’s equity, the company and its investors are ready to move ahead in... - December 12, 2007 - Cardiovascular Sciences, Inc.

ValveXchange has won the third annual Faegre & Benson Venture Showcase Award at the BioWest 2007 conference in Denver. The announcement is made by Chris Shapard, Deputy Director of the Colorado BioScience Association (CBSA), who says the $10,000 Venture Showcase Award was again provided by the Faegre & Benson law firm and announced at the Colorado Bioscience Association (CBSA) Awards luncheon at the Grand Hyatt Friday. - December 09, 2007 - Colorado BioScience Association - Featured Press Release

Candidacidin is the first naturopathic defense against yeast (Candida) which has been laboratory proven. Candida is now the fourth most prevalent organism found in bloodstream infections. Laboratory results validating antifungal properties are available on line. - December 08, 2007 - Florida Institute of Yeast

This week AnaSpec, one of the world’s largest providers of custom and catalog peptides, introduced eight (8) new catalog peptides and one new unusual amino acid. - December 07, 2007 - AnaSpec, Inc.

Gamma Medica-Ideas Inc. (GM-I), the world leader in developing and delivering digital medical imaging devices for the pre-clinical and clinical markets, has announced the sale of a fully digital multi-modality molecular imaging system for installation at Louisiana State University Health Sciences Center... - December 07, 2007 - Gamma Medica-Ideas

Continuing to rapidly expand its antibody offerings, AnaSpec added seventeen (17) new anti-Tau antibodies to its growing collection. Anti-Tau (paired181) - Cat# 54961, 50 µg Host: rabbit polyclonal; Species Reactivity: Human; Mouse; Rat; Applications: WB Anti-Tau (paired198;199;202;205) - Cat#... - December 06, 2007 - AnaSpec, Inc.